BioMarin Q1 2026 slides: revenue beats offset by margin pressure

🌐 Investing.com (CY) —
BioMarin Q1 2026 slides: revenue beats offset by margin pressure

AI Summary

BioMarin Pharmaceuticals reported its Q1 2026 results, showing a revenue beat; however, it was offset by margin pressure affecting overall performance. The company continues to navigate a competitive market environment while focusing on sustainable growth.

Markets BioMarin revenue margin pressure pharmaceuticals Q1 2026

Read original source →